IS5928A - Aðferðir og samsetningar til að hindra lyfjaþol - Google Patents

Aðferðir og samsetningar til að hindra lyfjaþol

Info

Publication number: IS5928A
Authority: IS; Iceland
Prior art keywords: combinations; methods; drug resistance; prevent drug; prevent
Prior art date: 1998-10-30

Application number

IS5928A

Other languages

English (en)

Other versions

IS2321B (is

Inventor

Ahmed Tahir

Original Assignee

Baker Norton Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-30

Filing date

2001-04-27

Publication date

2001-04-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26803748&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5928(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-04-27 Application filed by Baker Norton Pharmaceuticals, Inc. filed Critical Baker Norton Pharmaceuticals, Inc.

2001-04-27 Publication of IS5928A publication Critical patent/IS5928A/is

2007-12-15 Publication of IS2321B publication Critical patent/IS2321B/is

Links

206010059866 Drug resistance Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Investigating Or Analysing Biological Materials (AREA)

IS5928A 1998-10-30 2001-04-27 Aðferðir og blöndur til að fyrirbyggja þol gegn berkjuvíkkandi lyfjum IS2321B (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10650798P	1998-10-30	1998-10-30
US09/362,540 US6235725B1 (en)	1998-10-30	1999-07-28	Methods and compositions for the prevention of tolerance to medications
PCT/US1999/024034 WO2000025723A2 (en)	1998-10-30	1999-10-13	Methods and compositions for the prevention of tolerance to medications

Publications (2)

Publication Number	Publication Date
IS5928A true IS5928A (is)	2001-04-27
IS2321B IS2321B (is)	2007-12-15

Family

ID=26803748

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5928A IS2321B (is)	1998-10-30	2001-04-27	Aðferðir og blöndur til að fyrirbyggja þol gegn berkjuvíkkandi lyfjum

Country Status (25)

Country	Link
US (1)	US6235725B1 (is)
EP (1)	EP1124563B1 (is)
JP (1)	JP4585121B2 (is)
CN (2)	CN1329496A (is)
AR (2)	AR023911A1 (is)
AT (1)	ATE277621T1 (is)
AU (1)	AU760119B2 (is)
BR (1)	BR9915818A (is)
CA (1)	CA2348926C (is)
CO (1)	CO5160320A1 (is)
CY (1)	CY1107493T1 (is)
CZ (1)	CZ297914B6 (is)
DE (1)	DE69920734T2 (is)
ES (1)	ES2228173T3 (is)
HK (1)	HK1041596A1 (is)
HU (1)	HUP0302492A3 (is)
IL (2)	IL142865A0 (is)
IS (1)	IS2321B (is)
NO (1)	NO333194B1 (is)
NZ (1)	NZ511399A (is)
PL (1)	PL195592B1 (is)
PT (1)	PT1124563E (is)
SK (1)	SK285150B6 (is)
TW (1)	TW565451B (is)
WO (1)	WO2000025723A2 (is)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9902689D0 (en) *	1999-02-08	1999-03-31	Novartis Ag	Organic compounds
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
IL149984A0 (en) *	2000-10-12	2002-12-01	Boehringer Ingelheim Pharma	Novel tiotropium-containing inhalation powder
US20030055026A1 (en) *	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) *	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20030070679A1 (en) *	2001-06-01	2003-04-17	Boehringer Ingelheim Pharma Kg	Capsules containing inhalable tiotropium
US20030203930A1 (en) *	2001-10-26	2003-10-30	Imtiaz Chaudry	Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2003221335A (ja)	2001-10-26	2003-08-05	Dey Lp	慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US6702997B2 (en)	2001-10-26	2004-03-09	Dey, L.P.	Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030140920A1 (en) *	2001-10-26	2003-07-31	Dey L.P.	Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) *	2001-10-26	2003-10-09	Imtiaz Chaudry	Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
AU2003245794A1 (en) *	2002-02-18	2003-09-04	University Of Southampton	Glycosaminoglycan-dnase combination therapy
AU2003205898A1 (en) *	2002-02-18	2003-09-04	University Of Southampton	Combination therapy for respiratory disorders
DK1511466T4 (en) *	2002-02-18	2015-03-30	Ockham Biotech Ltd	Use of glycosaminoglycans, such as, for example, heparin, for the treatment of respiratory disorders such as COPD
WO2003080149A2 (en)	2002-03-20	2003-10-02	Mannkind Corporation	Inhalation apparatus
CA2483271A1 (en) *	2002-04-25	2003-11-06	Momenta Pharmaceuticals, Inc.	Methods and products for mucosal delivery
US20040023935A1 (en) *	2002-08-02	2004-02-05	Dey, L.P.	Inhalation compositions, methods of use thereof, and process for preparation of same
CA2496699C (en) *	2002-08-29	2012-07-17	Cipla Ltd.	Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
US7763280B2 (en) *	2002-11-28	2010-07-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Tiotropium containing powder formulation for inhalation
US20040109826A1 (en) *	2002-12-06	2004-06-10	Dey, L.P.	Stabilized albuterol compositions and method of preparation thereof
JP4851185B2 (ja) *	2003-05-16	2012-01-11	ジェレックスインターナショナル株式会社	アレルギー症状抑制剤及び空気濾過フィルター
TWI359675B (en) *	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
US20050043343A1 (en) *	2003-07-28	2005-02-24	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
ATE486064T1 (de)	2004-08-20	2010-11-15	Mannkind Corp	Katalyse der diketopiperazinsynthese
HUE025151T2 (en)	2004-08-23	2016-01-28	Mannkind Corp	Diceto-piperazine salts for drug delivery
KR101486397B1 (ko)	2005-09-14	2015-01-28	맨카인드 코포레이션	활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
KR20080096809A (ko)	2006-02-22	2008-11-03	맨카인드 코포레이션	디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
ES2929343T3 (es)	2008-06-13	2022-11-28	Mannkind Corp	Inhalador de polvo seco accionado por aspiración para la administración de fármacos
MX2010014240A (es)	2008-06-20	2011-03-25	Mankind Corp	Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion.
TWI494123B (zh)	2008-08-11	2015-08-01	Mannkind Corp	超快起作用胰島素之用途
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
WO2010105094A1 (en)	2009-03-11	2010-09-16	Mannkind Corporation	Apparatus, system and method for measuring resistance of an inhaler
MY157166A (en)	2009-06-12	2016-05-13	Mankind Corp	Diketopiperazine microparticles with defined specific surface areas
WO2011056889A1 (en)	2009-11-03	2011-05-12	Mannkind Corporation	An apparatus and method for simulating inhalation efforts
US20130090371A1 (en) *	2010-04-20	2013-04-11	President And Fellows Of Harvard College	Methods and compositions for inhibition of beta2-adrenergic receptor degradation
BR112012033060A2 (pt)	2010-06-21	2018-02-27	Mannkind Corp	métodos de sistema de liberação de fármaco em pó seco
AU2012236150B2 (en)	2011-04-01	2016-03-31	Mannkind Corporation	Blister package for pharmaceutical cartridges
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
BR112014009686A2 (pt)	2011-10-24	2018-08-07	Mannkind Corp	composição analgésica inalável, pó seco e método para tratar dor
AU2013289957B2 (en)	2012-07-12	2017-02-23	Mannkind Corporation	Dry powder drug delivery systems and methods
WO2014066856A1 (en)	2012-10-26	2014-05-01	Mannkind Corporation	Inhalable influenza vaccine compositions and methods
KR102246914B1 (ko)	2013-03-15	2021-04-30	맨카인드 코포레이션	미세결정성 디케토피페라진 조성물 및 방법
CN114848614A (zh)	2013-07-18	2022-08-05	曼金德公司	热稳定性干粉药物组合物和方法
EP3030294B1 (en)	2013-08-05	2020-10-07	MannKind Corporation	Insufflation apparatus
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
CN104069497A (zh) *	2014-06-27	2014-10-01	东莞市凯法生物医药有限公司	一种降低药物耐受性的组合物、方法及其应用
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
US20190070244A1 (en) *	2017-06-30	2019-03-07	The New Zealand Institute For Plant And Food Research Limited	Boysenberry compositions and methods of preparation and use thereof
US11617776B2 (en)	2017-08-08	2023-04-04	Odette M. Shaw	Boysenberry, apple, and blackcurrant compositions and methods of preparation and use therefor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1195497B (it)	1983-03-08	1988-10-19	Opocrin Spa	Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
US4906476A (en)	1988-12-14	1990-03-06	Liposome Technology, Inc.	Novel liposome composition for sustained release of steroidal drugs in lungs
US5380716A (en)	1988-12-15	1995-01-10	Glycomed, Inc.	Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
US5032679A (en)	1988-12-15	1991-07-16	Glycomed, Inc.	Heparin fragments as inhibitors of smooth muscle cell proliferation
US5192548A (en)	1990-04-30	1993-03-09	Riker Laboratoires, Inc.	Device
SE9302777D0 (sv)	1993-08-27	1993-08-27	Astra Ab	Process for conditioning substances
US5874063A (en)	1991-04-11	1999-02-23	Astra Aktiebolag	Pharmaceutical formulation
US5714376A (en)	1991-10-23	1998-02-03	Massachusetts Institute Of Technology	Heparinase gene from flavobacterium heparinum
DE69205177T2 (de)	1991-12-12	1996-03-21	Glaxo Group Ltd., Greenford, Middlesex	Pharmazeutische Aerosolformulierung.
US5736124A (en)	1991-12-12	1998-04-07	Glaxo Group Limited	Aerosol formulations containing P134a and particulate medicament
SK282826B6 (sk) *	1991-12-18	2002-12-03	Aktiebolaget Astra	Farmaceutická kompozícia na podávanie inhaláciou s obsahom formoterolu a budesonidu a jej použitie
US5690910A (en) *	1995-08-18	1997-11-25	Baker Norton Pharmaceuticals, Inc.	Method for treating asthma

1999
- 1999-07-28 US US09/362,540 patent/US6235725B1/en not_active Expired - Lifetime
- 1999-10-13 CZ CZ20011518A patent/CZ297914B6/cs not_active IP Right Cessation
- 1999-10-13 EP EP99971300A patent/EP1124563B1/en not_active Expired - Lifetime
- 1999-10-13 BR BR9915818-3A patent/BR9915818A/pt not_active Application Discontinuation
- 1999-10-13 CN CN99813923A patent/CN1329496A/zh active Pending
- 1999-10-13 CA CA2348926A patent/CA2348926C/en not_active Expired - Fee Related
- 1999-10-13 CN CNB2004100629128A patent/CN100352448C/zh not_active Expired - Fee Related
- 1999-10-13 PT PT99971300T patent/PT1124563E/pt unknown
- 1999-10-13 PL PL99364727A patent/PL195592B1/pl unknown
- 1999-10-13 HU HU0302492A patent/HUP0302492A3/hu not_active Application Discontinuation
- 1999-10-13 IL IL14286599A patent/IL142865A0/xx active IP Right Grant
- 1999-10-13 WO PCT/US1999/024034 patent/WO2000025723A2/en not_active Ceased
- 1999-10-13 HK HK02103273.0A patent/HK1041596A1/zh unknown
- 1999-10-13 AU AU12051/00A patent/AU760119B2/en not_active Ceased
- 1999-10-13 AT AT99971300T patent/ATE277621T1/de active
- 1999-10-13 JP JP2000579168A patent/JP4585121B2/ja not_active Expired - Fee Related
- 1999-10-13 NZ NZ511399A patent/NZ511399A/en not_active IP Right Cessation
- 1999-10-13 ES ES99971300T patent/ES2228173T3/es not_active Expired - Lifetime
- 1999-10-13 SK SK590-2001A patent/SK285150B6/sk not_active IP Right Cessation
- 1999-10-13 DE DE69920734T patent/DE69920734T2/de not_active Expired - Lifetime
- 1999-10-28 AR ARP990105443A patent/AR023911A1/es not_active Application Discontinuation
- 1999-10-29 CO CO99068642A patent/CO5160320A1/es unknown
- 1999-11-09 TW TW088118719A patent/TW565451B/zh not_active IP Right Cessation
2001
- 2001-04-27 NO NO20012097A patent/NO333194B1/no not_active IP Right Cessation
- 2001-04-27 IS IS5928A patent/IS2321B/is unknown
- 2001-04-30 IL IL142865A patent/IL142865A/en not_active IP Right Cessation
2004
- 2004-12-06 CY CY20041101437T patent/CY1107493T1/el unknown
2011
- 2011-09-07 AR ARP110103258A patent/AR082913A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2348926A1 (en)	2000-05-11
IS2321B (is)	2007-12-15
NO333194B1 (no)	2013-04-02
CN1572303A (zh)	2005-02-02
SK5902001A3 (en)	2002-07-02
HK1041596A1 (zh)	2002-07-12
DE69920734T2 (de)	2005-10-06
AU760119B2 (en)	2003-05-08
DE69920734D1 (de)	2004-11-04
WO2000025723A3 (en)	2000-07-27
JP2002535245A (ja)	2002-10-22
AR023911A1 (es)	2002-09-04
EP1124563B1 (en)	2004-09-29
HUP0302492A2 (hu)	2003-11-28
CZ20011518A3 (cs)	2002-04-17
CO5160320A1 (es)	2002-05-30
CA2348926C (en)	2011-08-23
AR082913A2 (es)	2013-01-16
ATE277621T1 (de)	2004-10-15
CN100352448C (zh)	2007-12-05
CZ297914B6 (cs)	2007-04-25
CN1329496A (zh)	2002-01-02
HUP0302492A3 (en)	2005-05-30
NZ511399A (en)	2004-09-24
BR9915818A (pt)	2002-06-18
IL142865A0 (en)	2002-03-10
PL364727A1 (en)	2004-12-13
AU1205100A (en)	2000-05-22
TW565451B (en)	2003-12-11
SK285150B6 (sk)	2006-07-07
WO2000025723A2 (en)	2000-05-11
JP4585121B2 (ja)	2010-11-24
PL195592B1 (pl)	2007-10-31
US6235725B1 (en)	2001-05-22
NO20012097D0 (no)	2001-04-27
EP1124563A4 (en)	2002-01-02
CY1107493T1 (el)	2013-03-13
IL142865A (en)	2006-07-05
NO20012097L (no)	2001-06-15
ES2228173T3 (es)	2005-04-01
EP1124563A2 (en)	2001-08-22
PT1124563E (pt)	2005-01-31

Publication	Publication Date	Title
IS5928A (is)	2001-04-27	Aðferðir og samsetningar til að hindra lyfjaþol
NO20022334L (no)	2002-07-09	Ny sammensetning og anvendelse
NO20021449D0 (no)	2002-03-22	Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
NO20014560D0 (no)	2001-09-19	Quinasoliner og terapautisk anvendelse derav
NO20004544D0 (no)	2000-09-12	Forbedret pumpeanordning og forbedrede fremgangsmÕter
IS6183A (is)	2001-11-29	Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa
NO20005692D0 (no)	2000-11-10	Forbedringer i og vedrörende bygningselementer, og fremgangsmåter vedrörende samme
NO20005630D0 (no)	2000-11-08	Mikro-laser-kuler og strukturer, og tilhörende fremgangsmåter
NO20003928D0 (no)	2000-08-03	Støtbarriere og barriere-element
NO20032753D0 (no)	2003-06-17	Forbindelse og anvendelse derav
DK1112251T3 (da)	2003-09-01	Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater
DK1339292T3 (da)	2010-04-12	Sammensætning og fremgangsmåde
NO20012567D0 (no)	2001-05-25	Azepinoindolderivater, fremstilling og anvendelse derav
DE60031119D1 (de)	2006-11-16	Richtbohrvorrichtung und -verfahren
DK1242095T3 (da)	2013-08-12	Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
NO991150D0 (no)	1999-03-10	Pyrazolopyrimidiner og pyrazolotriaziner
NO20010197L (no)	2001-03-12	Nedihulls multiplexer og relaterte fremgangsmater
NO20006488D0 (no)	2000-12-19	Sammensetning og anvendelse
LV12624B (lv)	2001-09-20	Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
NO20006604D0 (no)	2000-12-22	Fremgangsmåter og transdermale sammensetninger for lindring av smerte
DK1112003T3 (da)	2003-08-04	Ny sammensætning og anvendelse
IS6096A (is)	2001-09-28	Latar fyrir LFA-1 bindingu við ICAM og notkun á þeim
DK1311731T3 (da)	2008-03-17	Fremgangsmåde og arrangement til stolpesystem
DK1164996T3 (da)	2004-02-16	Transdermalt terapeutisk system med nikotin og tilsat monoterpenketoner
DK1066261T3 (da)	2006-01-30	Pyridinderivat og farmaceutisk præparat indeholdende samme